Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > mid-month ...
View:
Post by MrMugsy on Jul 09, 2021 5:13pm

mid-month ...

We've got mid-month fast approaching.
That's when we're supposed to get a Letter to Shareholders.
If we're lucky we get it before Friday.

Looking for the wording on the NASDAQ listing ... commitment or non-commitment.
Tone on negotiations.
Also, any other updates on drug development.

Meet us halfway ... just give us one OTENA partnership by then.
I'd even take a product development partnership.

: )
Comment by CandyC on Jul 09, 2021 10:49pm
Isn't one of the requirements for Nasdaq is to be over $3.00usd for a extended time?
Comment by MrMugsy on Jul 09, 2021 11:55pm
It probably is $3 USD ... so ... they need to create demand. Was watching the ask price today - if someone wanted to buy 5,000-10,000 shares at market, they would have drove the price well over $4.  Demand doesn't exist and it hasn't existed since February. Need the NAZ to create demand and we need the demand to get to the NAZ ... catch 22. I think there's a plan - unfortunately ...more  
Antibe Therapeutics Inc(Pre-Merger)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities